Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (2210)	11/7/1997 3:52:00 PM
From: Tokyo VD	Read Replies (1) \| Respond to of 23519

There is a dow jones story on Vivus.

To: BigKNY3 who wrote (2210)	11/7/1997 5:10:00 PM
From: Tunica Albuginea	Read Replies (2) \| Respond to of 23519

BigKNY3, it is impotant for physicians to find out NEGATIVE things about ANY drug, BEFORE it is approved.This is for the not so obvious purpose ( to you ) of -assuring patient safety; first. -assuring legal safety to the physician; second.( Nobody wants to go through another silicon breast implant debacle as has occured to so many innicent plastic surgeons. Perhaps if you, Braddy and Leo had spent a little more time witnessing/participating in/drug calamities ( as physicians have ) you would redefine your teerms more as concern rather than obsession. TA PS Brokers in Wall Street should start to worry more about improving things that they have some expertise in, such as improving their investment abilities, and less about trying to learn about medicine and other thousand of specilized fields. IMHO.